YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJUV1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,270
Award facts
- Contract value 100% obligated
- $22,270.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,270.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. This delivery order, issued on December 11, 2025, with an ultimate completion date of January 5, 2026, carries no set-aside designation, indicating the company competed successfully in an unrestricted procurement environment. The award falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to provide comprehensive pharmaceutical supply chain support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has been a registered federal contractor since 2001 and demonstrates substantial pharmaceutical distribution capabilities across multiple therapeutic categories, including vaccines, specialty medications, biologics, and medical consumables. The company holds a single-award IDC under PPV-G GEN V (contract SPE2DR) valued at $499,999,999 with a completion date of December 31, 2036, positioning it as a critical regional pharmaceutical supplier for military medical operations. This YF-VAX delivery order exemplifies the company's role in fulfilling specialized vaccine requirements within the Department of Defense's global healthcare supply network.
Quick answers
Who was awarded contract SPE2DR26FJUV1?
SPE2DR26FJUV1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FJUV1 worth?
The government has obligated $22,270 on SPE2DR26FJUV1.
Is contract SPE2DR26FJUV1 an order under another contract?
Yes. SPE2DR26FJUV1 is a delivery order under SPE2DR25D9329, an indefinite delivery contract.
Was contract SPE2DR26FJUV1 competed?
The extent of competition for SPE2DR26FJUV1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award